Vir Biotechnology, Inc.
Developing antibody-based medicines
- B2B
About Vir Biotechnology, Inc.
Immunology company focusing on developing transformative medicines for infectious diseases using monoclonal antibodies and cutting-edge technologies like AI and machine learning
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- san francisco, california, United States
- Founded
- 2016
- Revenue
- $68.6MFY2025, publicly reported
- Website
- vir.bio
Vir Biotechnology, Inc. at a glance
Vir Biotechnology, Inc. is a B2B company in the Biotechnology Research industry, headquartered in san francisco, california, United States.
Vir Biotechnology, Inc. was founded in 2016.
Vir Biotechnology, Inc. has 251–1,000 employees.
Vir Biotechnology, Inc.'s revenue is $68.6M (FY2025, publicly reported).
Selling to companies like Vir Biotechnology, Inc.?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies